NIH-funded research NIH-funded research

Using sound waves to deliver non-opioid pain relief for chronic pain

Official title: Clinical Translation of Ultrasonic Ketamine Uncaging for Non-Opioid Therapy of Chronic Pain

Funded at Stanford University · NIH-10899406 · Data updated 2026-11-12

This research explores a new way to deliver a non-opioid medication, ketamine, directly to a specific brain area using ultrasound to help people with chronic pain.

More Chronic Pain research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionStanford University
NIH-funded
Lab location1 site (Stanford, United States)
Project startSeptember 30, 2019
Project endMay 31, 2026
Funding year2025
Award (this year)$1,318,377
NIH project number5UG3NS115637-04
Project IDNIH-10899406 on NIH RePORTER

Who could benefit from this research

Could help

This research is ultimately intended for individuals experiencing chronic pain, particularly those for whom current treatments are insufficient or who wish to avoid opioid medications.

Less likely to help

Patients whose pain is not related to the anterior cingulate cortex or who do not have chronic pain may not benefit from this specific treatment approach.

What this research studies

Many people with chronic pain rely on opioid medications, which can lead to addiction. This project focuses on a brain area called the anterior cingulate cortex (ACC), which plays a key role in chronic pain. We are developing a method to deliver ketamine, a non-opioid drug, precisely to the ACC using special sound waves. This approach aims to provide strong pain relief without affecting the rest of the body, potentially offering a safer and more effective treatment for long-lasting pain.

Why it matters

Potential benefit: If successful, this approach could offer a new, non-addictive treatment option for chronic pain that provides long-lasting relief with fewer side effects than current systemic medications.

How similar studies have gone: While local therapies to the ACC have shown clinical benefit for chronic pain, this specific method of ultrasonic drug delivery is a novel and untested approach in humans.

Where this research is happening

  • Stanford University
    Stanford, United States
    Active

Researchers

  • Principal investigator: Airan, Raag D — Stanford University
  • Study coordinator: Airan, Raag D

Related research

Other NIH-funded projects on the same topics.

  • Ultrasound-triggered ketamine delivery to a brain region to treat chronic pain

    A Stanford team is testing a new way to give ketamine exactly where it’s needed in the brain to relieve chronic pain without opioids.

    NIH research Stanford University · Stanford, United States · NIH-11540446

  • Ultrasound-triggered ketamine release to target brain pain circuits

    Using focused ultrasound to release tiny amounts of ketamine directly in a specific brain area to relieve long-term chronic pain without opioids for people with persistent pain.

    NIH research Stanford University · Stanford, United States · NIH-11379707

  • Using ultrasound to activate ketamine for treating chronic pain without opioids

    This study is looking at a new way to help people with chronic pain by using sound waves to activate ketamine in the brain, aiming to ease the emotional struggles that come with pain and improve overall treatment, which could also help those dealing with opioid use issues.

    NIH research Stanford University · Stanford, United States · NIH-11090278

  • Motor cortex tricks to ease chronic pain

    A study in rodents and people tests whether non-invasive brain stimulation of the motor cortex can reduce chronic pain and how best to target it.

    NIH research Weill Medical Coll of Cornell Univ · New York, United States · NIH-11621209

  • Human pain center study to map normal and migraine-trigeminal neurons

    A large NIH-funded project will map and study the human trigeminal neurons involved in migraines to understand what changes in these cells during headache conditions.

    NIH research University of Pennsylvania · Philadelphia, United States · NIH-11615140

  • Understanding human pain neurons to improve migraine care

    Researchers are studying human pain-sensing neurons to uncover what makes migraine start and persist, with the goal of better treatments for people who experience migraines.

    NIH research University of Pennsylvania · Philadelphia, United States · NIH-11615139

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.